Pulmonx Long Term Debt vs Deferred Long Term Liab Analysis

LUNG Stock

USD 6.97 0.41 5.56%

Pulmonx Corp financial indicator trend analysis is much more than just breaking down Pulmonx Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pulmonx Corp is a good investment. Please check the relationship between Pulmonx Corp Long Term Debt and its Deferred Long Term Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pulmonx Corp Long Term Debt account and Deferred Long Term Liab. At this time, the significance of the direction appears to have pay attention.

The correlation between Pulmonx Corp's Long Term Debt and Deferred Long Term Liab is -0.71. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Pulmonx Corp, assuming nothing else is changed. The correlation between historical values of Pulmonx Corp's Long Term Debt and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Pulmonx Corp are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Long Term Debt i.e., Pulmonx Corp's Long Term Debt and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.71

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Long Term Debt

Long-term debt is a debt that Pulmonx Corp has held for over one year. Long-term debt appears on Pulmonx Corp balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Pulmonx Corp balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Pulmonx Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pulmonx Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.The Pulmonx Corp's current Selling General Administrative is estimated to increase to about 108.4 M, while Tax Provision is projected to decrease to roughly 339.7 K.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	4.0M	1.9M	2.2M	1.8M
Interest Income	1.5M	4.8M	5.5M	5.8M

Depreciation And Amortization Interest Income

Pulmonx Corp fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Inventory	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Receivables	Other Assets	Other Current Assets	Intangible Assets	Short Long Term Debt Total	Other Current Liab	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total
Total Assets		0.87	0.81	0.82	-0.88	0.66	0.91	0.7	0.92	0.15	0.06	1.0	0.84	0.85	0.86	0.75	0.25	0.97	-0.14	-0.07	0.7	-0.8	0.95	-0.61	-0.9	0.88
Total Current Liabilities	0.87		0.53	0.59	-0.97	0.77	0.61	0.9	0.96	0.42	0.27	0.84	0.84	0.79	0.69	0.94	0.23	0.91	-0.18	0.11	0.88	-0.76	0.85	-0.48	-0.59	0.92
Total Stockholder Equity	0.81	0.53		0.99	-0.53	0.14	0.8	0.31	0.69	-0.46	0.19	0.82	0.75	0.68	0.58	0.49	0.1	0.79	-0.53	0.1	0.45	-0.42	0.67	-0.66	-0.78	0.66
Net Tangible Assets	0.82	0.59	0.99		-0.58	0.17	0.78	0.39	0.74	-0.42	0.27	0.83	0.79	0.7	0.56	0.57	0.06	0.82	-0.57	0.18	0.51	-0.44	0.68	-0.7	-0.75	0.7
Retained Earnings	-0.88	-0.97	-0.53	-0.58		-0.81	-0.68	-0.89	-0.95	-0.44	-0.14	-0.86	-0.83	-0.83	-0.73	-0.89	-0.32	-0.91	0.07	-0.05	-0.84	0.73	-0.87	0.49	0.65	-0.93
Accounts Payable	0.66	0.77	0.14	0.17	-0.81		0.55	0.67	0.69	0.77	-0.26	0.65	0.45	0.58	0.77	0.65	0.46	0.64	0.34	-0.28	0.67	-0.81	0.79	-0.13	-0.55	0.71
Cash	0.91	0.61	0.8	0.78	-0.68	0.55		0.46	0.7	0.05	-0.14	0.94	0.65	0.78	0.87	0.46	0.22	0.8	0.04	-0.17	0.46	-0.7	0.85	-0.61	-0.99	0.69
Long Term Debt	0.7	0.9	0.31	0.39	-0.89	0.67	0.46		0.83	0.52	0.27	0.67	0.71	0.64	0.47	0.88	0.01	0.73	-0.01	0.29	0.75	-0.55	0.62	-0.51	-0.41	0.74
Inventory	0.92	0.96	0.69	0.74	-0.95	0.69	0.7	0.83		0.23	0.2	0.9	0.86	0.78	0.73	0.93	0.21	0.97	-0.29	0.12	0.86	-0.74	0.88	-0.53	-0.67	0.95
Total Liab	0.15	0.42	-0.46	-0.42	-0.44	0.77	0.05	0.52	0.23		-0.24	0.13	0.0	0.15	0.34	0.31	0.22	0.13	0.69	-0.27	0.31	-0.49	0.31	0.2	-0.06	0.22
Short Long Term Debt	0.06	0.27	0.19	0.27	-0.14	-0.26	-0.14	0.27	0.2	-0.24		0.04	0.41	0.22	-0.22	0.3	-0.42	0.14	-0.63	0.65	0.37	0.12	-0.07	-0.34	0.19	0.21
Total Current Assets	1.0	0.84	0.82	0.83	-0.86	0.65	0.94	0.67	0.9	0.13	0.04		0.82	0.85	0.87	0.72	0.25	0.95	-0.12	-0.09	0.66	-0.79	0.94	-0.62	-0.93	0.86
Short Term Debt	0.84	0.84	0.75	0.79	-0.83	0.45	0.65	0.71	0.86	0.0	0.41	0.82		0.8	0.49	0.79	0.32	0.86	-0.44	0.19	0.67	-0.48	0.73	-0.75	-0.62	0.82
Common Stock	0.85	0.79	0.68	0.7	-0.83	0.58	0.78	0.64	0.78	0.15	0.22	0.85	0.8		0.73	0.66	0.27	0.85	-0.17	0.13	0.77	-0.61	0.82	-0.53	-0.73	0.88
Property Plant Equipment	0.86	0.69	0.58	0.56	-0.73	0.77	0.87	0.47	0.73	0.34	-0.22	0.87	0.49	0.73		0.51	0.26	0.8	0.17	-0.33	0.61	-0.92	0.94	-0.23	-0.87	0.76
Net Receivables	0.75	0.94	0.49	0.57	-0.89	0.65	0.46	0.88	0.93	0.31	0.3	0.72	0.79	0.66	0.51		0.13	0.83	-0.35	0.28	0.87	-0.6	0.71	-0.51	-0.42	0.86
Other Assets	0.25	0.23	0.1	0.06	-0.32	0.46	0.22	0.01	0.21	0.22	-0.42	0.25	0.32	0.27	0.26	0.13		0.28	0.13	-0.58	0.08	-0.24	0.41	0.09	-0.26	0.3
Other Current Assets	0.97	0.91	0.79	0.82	-0.91	0.64	0.8	0.73	0.97	0.13	0.14	0.95	0.86	0.85	0.8	0.83	0.28		-0.27	0.01	0.8	-0.76	0.94	-0.51	-0.78	0.95
Intangible Assets	-0.14	-0.18	-0.53	-0.57	0.07	0.34	0.04	-0.01	-0.29	0.69	-0.63	-0.12	-0.44	-0.17	0.17	-0.35	0.13	-0.27		-0.54	-0.33	-0.16	-0.03	0.34	-0.07	-0.29
Short Long Term Debt Total	-0.07	0.11	0.1	0.18	-0.05	-0.28	-0.17	0.29	0.12	-0.27	0.65	-0.09	0.19	0.13	-0.33	0.28	-0.58	0.01	-0.54		0.36	0.4	-0.26	-0.4	0.28	0.14
Other Current Liab	0.7	0.88	0.45	0.51	-0.84	0.67	0.46	0.75	0.86	0.31	0.37	0.66	0.67	0.77	0.61	0.87	0.08	0.8	-0.33	0.36		-0.62	0.72	-0.3	-0.39	0.93
Other Liab	-0.8	-0.76	-0.42	-0.44	0.73	-0.81	-0.7	-0.55	-0.74	-0.49	0.12	-0.79	-0.48	-0.61	-0.92	-0.6	-0.24	-0.76	-0.16	0.4	-0.62		-0.91	0.14	0.72	-0.71
Property Plant And Equipment Net	0.95	0.85	0.67	0.68	-0.87	0.79	0.85	0.62	0.88	0.31	-0.07	0.94	0.73	0.82	0.94	0.71	0.41	0.94	-0.03	-0.26	0.72	-0.91		-0.37	-0.86	0.89
Current Deferred Revenue	-0.61	-0.48	-0.66	-0.7	0.49	-0.13	-0.61	-0.51	-0.53	0.2	-0.34	-0.62	-0.75	-0.53	-0.23	-0.51	0.09	-0.51	0.34	-0.4	-0.3	0.14	-0.37		0.56	-0.41
Net Debt	-0.9	-0.59	-0.78	-0.75	0.65	-0.55	-0.99	-0.41	-0.67	-0.06	0.19	-0.93	-0.62	-0.73	-0.87	-0.42	-0.26	-0.78	-0.07	0.28	-0.39	0.72	-0.86	0.56		-0.65
Non Current Assets Total	0.88	0.92	0.66	0.7	-0.93	0.71	0.69	0.74	0.95	0.22	0.21	0.86	0.82	0.88	0.76	0.86	0.3	0.95	-0.29	0.14	0.93	-0.71	0.89	-0.41	-0.65

Click cells to compare fundamentals

Pulmonx Corp Account Relationship Matchups

Pulmonx Corp fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	263.7M	235.2M	193.7M	177.8M	204.4M	214.7M
Total Current Liabilities	12.5M	17.6M	18.5M	23.2M	26.6M	28.0M
Total Stockholder Equity	226.1M	193.2M	154.0M	118.3M	136.1M	142.9M
Net Tangible Assets	(190.2M)	223.4M	190.6M	151.7M	174.4M	183.1M
Retained Earnings	(242.7M)	(291.4M)	(350.3M)	(411.2M)	(370.0M)	(351.5M)
Accounts Payable	1.5M	1.6M	1.8M	1.5M	1.7M	1.2M
Cash	231.6M	148.5M	101.7M	83.5M	96.1M	58.5M
Long Term Debt	17.4M	17.3M	17.2M	35.1M	40.4M	42.4M
Inventory	10.7M	16.3M	14.6M	16.7M	19.3M	20.2M
Total Liab	37.6M	41.9M	39.7M	59.5M	68.4M	61.4M
Total Current Assets	250.0M	208.0M	169.0M	150.4M	173.0M	181.6M
Short Term Debt	4.5M	2.3M	6.5M	5.2M	6.0M	6.3M
Common Stock	36K	37K	38K	39K	44.9K	25.0K
Property Plant Equipment	7.5M	10.5M	12.9M	5.3M	6.1M	4.1M
Net Receivables	4.2M	6.6M	8.7M	13.0M	15.0M	15.7M
Other Assets	536K	731K	5.8M	1.0	1.15	1.09
Other Current Assets	3.1M	4.8M	4.0M	3.6M	4.1M	4.3M
Intangible Assets	400K	277K	154K	31K	27.9K	26.5K
Short Long Term Debt Total	27.2M	26.5M	24.4M	41.4M	47.6M	32.1M
Other Current Liab	6.4M	13.4M	10.0M	16.2M	18.7M	11.5M
Other Liab	43K	62K	37K	94K	84.6K	58.1K
Property Plant And Equipment Net	10.5M	12.9M	10.5M	7.4M	8.5M	9.0M
Current Deferred Revenue	71K	163K	120K	104K	93.6K	102.7K
Net Debt	(204.3M)	(122.0M)	(77.3M)	(42.1M)	(37.9M)	(39.8M)
Non Current Assets Total	13.7M	27.2M	24.7M	27.4M	31.5M	20.0M
Non Currrent Assets Other	536K	252K	5.4M	3.2M	3.6M	2.2M
Cash And Short Term Investments	231.6M	180.0M	141.1M	117.1M	134.7M	128.8M
Common Stock Total Equity	19K	36K	37K	38K	43.7K	32.3K
Common Stock Shares Outstanding	35.7M	36.1M	37.1M	38.0M	43.7M	37.2M
Liabilities And Stockholders Equity	263.7M	235.2M	193.7M	177.8M	204.4M	172.1M
Non Current Liabilities Total	25.0M	24.4M	21.2M	36.3M	32.7M	31.0M
Capital Lease Obligations	9.9M	9.0M	7.1M	4.2M	4.8M	6.8M
Other Stockholder Equity	467.1M	482.9M	502.7M	526.8M	605.8M	333.1M
Net Invested Capital	243.5M	210.7M	171.3M	155.6M	178.9M	187.8M
Property Plant And Equipment Gross	10.5M	4.8M	4.7M	12.3M	14.1M	7.3M
Accumulated Other Comprehensive Income	1.7M	1.7M	1.6M	2.6M	3.0M	1.9M
Capital Stock	36K	37K	38K	39K	44.9K	34.1K
Net Working Capital	237.5M	190.5M	150.5M	127.3M	146.4M	134.9M

Currently Active Assets on Macroaxis

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications
DIA	SPDR Dow Jones
SPY	SPDR SP 500

When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:

How To Invest In Pulmonx

Details

Is Pulmonx Stock a good investment?

Details

What is Pulmonx Corp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.47)

Revenue Per Share

2.043

Quarterly Revenue Growth

0.154

Return On Assets

(0.20)

Return On Equity

(0.52)

The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pulmonx Long Term Debt vs Deferred Long Term Liab Analysis

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Long Term Debt

Deferred Long Term Liab

Pulmonx Corp fundamental ratios Correlations

Pulmonx Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pulmonx Corp fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Other Current Assets	+ 0.97	Total Assets
Other Current Assets	+ 0.97	Inventory
Inventory	+ 0.96	Total Current Liabilities
Property Plant And Equipment Net	+ 0.95	Total Assets

Net Debt	- 0.99	Cash
Retained Earnings	- 0.97	Total Current Liabilities
Inventory	- 0.95	Retained Earnings
Net Debt	- 0.93	Total Current Assets
Non Current Assets Total	- 0.93	Retained Earnings
Other Liab	- 0.92	Property Plant Equipment